VYNE icon

VYNE Therapeutics
VYNE

Overview Fund Trends Analyst Outlook Journalist POV

54 hedge funds and large institutions have $12.5M invested in VYNE Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

47% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 19

53% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 17

Holders
54
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$95K
Puts
$26K
Net Calls
Net Calls Change

Top Buyers

1
+$1.48M
2
+$169K
3
+$128K
4
Goldman Sachs
Goldman Sachs
New York
+$75.1K
5
VF
Virtu Financial
New York
+$68.4K

Top Sellers

1
-$1.81M
2
-$994K
3
-$347K
4
CM
CM Management
Florida
-$200K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$194K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$28K
27
$27K
28
$26K
29
$26K
30
$22K
31
$20K
32
$20K
33
$18K
34
$17K
35
$8K
36
$3K
37
$2K
38
$2K
39
$2K
40
$2K
41
$2K
42
$2K
43
$2K
44
$1K
45
$1K
46
$1K
47
$1K
48
$1K
49
$1K
50
–
1
2
3